Skip to content
Axiocairn

Model Desk Daily

Model Desk Daily · 2026-11-06 · Closing edition

Axiocairn · Data date: . Method: Descriptive comparison of the dated observations shown in this report; historical observations do not establish future outcomes.

Summary

  • Model simulation states do not establish actual holdings or fills; every figure is taken directly from each model's data for the day.
  • Research limitations: 10Y and OAS are 2026-10-29, the 10Y-2Y spread is 2026-10-30, and as_of for equity, sector and volatility data is not provided, VIX whether it falls on the same day as the stock price remains to be verified; ISM release date 11-02 or 11-03 remains to be verified, PMI 54.5 and 57.6 are forecast, and GDPNow 3.2% has no date; CPI has index points only (336.298, 2026-09); year-over-year rates, the Fed target range, historical valuation percentiles, earnings expectations, positioning, volume and pre/post-event rate data are not provided, so crowding cannot be judged; credit has only 3 series, uses the current version, and the version published at the time was not reconstructed.
  • Since the last report Baseline: 2026-11-05 close | Observation date 2026-11-05 → 2026-11-06 close | Observation date 2026-11-06 Model Change HOT Sector Rotation No additions; no endings. SnapBack Mean Reversion No additions; no endings. BIO Biotech Swing No additions; no endings. Spread oversold rebound spread No additions; no endings. LC leader capture No additions; no endings.

2026-11-06 ET

Model simulation states do not establish actual holdings or fills; every figure is taken directly from each model's data for the day.

Report date2026-11-06

Reading route

Since the last report

Baseline: 2026-11-05 close | Observation date 2026-11-05 → 2026-11-06 close | Observation date 2026-11-06

ModelChange
HOT Sector Rotation
No additions; no endings.
SnapBack Mean Reversion
No additions; no endings.
BIO Biotech Swing
No additions; no endings.
Spread oversold rebound spread
No additions; no endings.
LC leader capture
No additions; no endings.

HOT

Context from the current weekly view

Market Backdrop · As of last Friday's closeWeekly driver 🔻 equal-weight leadership (breadth-driven market) · SPY 5d -0.6% vs equal-weight +0.8% (gap -1.4pp)Large-cap proxy QQQ−SPY 5d -1.4pp50DMA sector/industry ETF sample7/11

Research limitations: 10Y and OAS are 2026-10-29, the 10Y-2Y spread is 2026-10-30, and as_of for equity, sector and volatility data is not provided, VIX whether it falls on the same day as the stock price remains to be verified; ISM release date 11-02 or 11-03 remains to be verified, PMI 54.5 and 57.6 are forecast, and GDPNow 3.2% has no date; CPI has index points only (336.298, 2026-09); year-over-year rates, the Fed target range, historical valuation percentiles, earnings expectations, positioning, volume and pre/post-event rate data are not provided, so crowding cannot be judged; credit has only 3 series, uses the current version, and the version published at the time was not reconstructed.

Research source:Weekly view · 2026-11-02

Observation date: 2026-11-06

ItemReading
NAV
92.57
This month
▼ -5.8%
Year to date
▲ +145.2%
SPY
735.35
SPY SMA50
765.15
SPY SMA200
727.64
Breadth
36%
VIX
25.16
Average model elapsed days
11.00
Latest quote
After-hours
Quote as of ET
17:40
Symbols quoted
3 / 4

Simulated positions

InstrumentSectorHeat rankModel start dateModel start priceLatest close (as of 2026-11-06)Historical price changeModel upper boundModel upper-bound typevs SMA50Model continuation
CURE
XLV
4
2026-10-30
172.79
166.37
▼ -3.7%
241.90
Principal Recovery
▲ +6.7%
Yes
NAIL
ITB
1
2026-11-03
36.50
36.09
▼ -1.1%
51.10
Principal Recovery
▲ +7.8%
Yes

Latest-quote context (context only; model markers unchanged)

InstrumentTypeReference closeAfter-hours (as of 17:40 ET)Quote time ETvs referenceStart or triggervs start or triggerNearest model levelvs levelCrossing hint
CURE
Model position
166.37
—
—
—
—
—
—
—
No extended-hours trade
NAIL
Model position
36.09
36.09
17:13
▼ -0.0%
36.50
▼ -1.1%
51.10
▼ -29.4%
Not crossed
GDX
Coil
87.58
87.45
17:35
▼ -0.1%
88.53
▼ -1.2%
—
—
Below trigger
GLD
Coil
372.58
373.12
17:27
▲ +0.1%
382.71
▼ -2.5%
—
—
Below trigger

Next-day model end records

Source lists 0 rows 0.

Next-day model start records

Source lists 0 rows 0.

Sector heat ranking

RankSectorInstrumentHeatGateIn model recordvs SMA50
1
ITB
NAIL
▲ +20.2%
Yes
Yes
▲ +7.8%
2
JETS
JETS
▲ +17.2%
Yes
No
▲ +3.5%
3
TAN
TAN
▲ +12.9%
Yes
No
▲ +2.8%
4
XLV
CURE
▲ +10.7%
Yes
Yes
▲ +6.7%
5
KRE
DPST
▲ +10.0%
Yes
No
▲ +0.7%
6
XLY
WANT
▲ +9.9%
Yes
No
▲ +3.8%
7
XBI
LABU
▲ +9.7%
No
No
▼ -2.0%
8
GDX
NUGT
▲ +9.5%
No
No
▼ -2.2%
9
XLF
FAS
▲ +9.3%
Yes
No
▲ +2.4%
10
TLT
TMF
▲ +8.3%
Yes
No
▲ +2.1%

Heat Radar

SectorRankTags3-day slope5-day slopeVolume z-score
TAN
3
🔥Warming
▲ +10.7%
▲ +17.8%
0.42
XBI
7
🔥Warming
▲ +4.5%
▲ +1.3%
0.15
GDX
8
🔥Warming
▲ +19.4%
▲ +16.5%
-0.18
KWEB
12
👀Early stage
▲ +9.5%
▲ +9.7%
-0.05
GLD
13
👀Early stage
▲ +7.0%
▲ +6.1%
-0.07
SLV
16
👀Early stage
▲ +12.8%
▲ +12.1%
-0.17
URA
19
👀Early stage
▲ +7.4%
▲ +8.2%
0.19

Coiling breakouts

SectorRankGradeLatest close (as of 2026-11-06)Trigger priceDistance to triggerFired
GDX
8
C
87.58
88.53
▲ +1.1%
No
GLD
13
C
372.58
382.71
▲ +2.7%
No

Recent model records

InstrumentModel startModel endModel start priceModel end priceHistorical price change
SOXL
2026-09-22
2026-10-14
137.74
118.96
▼ -13.6%
IGV
2026-10-14
2026-10-15
109.30
106.69
▼ -2.4%
BOIL
2026-10-14
2026-10-16
22.62
20.37
▼ -10.0%
GUSH
2026-10-16
2026-10-30
48.12
50.33
▲ +4.6%
ERX
2026-10-15
2026-11-03
121.78
116.76
▼ -4.1%

SnapBack

Observation date: 2026-11-06

ItemReading
Account equity
94,710.75
This month
▼ -5.4%
Since takeover
▼ -8.6%
Slots
Free of 0 6
Average model elapsed days
9.41
Latest quote
After-hours
Quote as of ET
17:40
Symbols quoted
6 / 8

Simulated positions

InstrumentLegModel start dateModel start priceLatest close (as of 2026-11-06)Historical price changeModel elapsed daysDays leftModel end lineModel end levelTo model end lineNext-day model end marker
FTNT
A
2026-11-02
133.80
118.84
▼ -11.2%
5
15
SMA10 target
144.27
▼ -17.6%
No
VLO
A
2026-10-28
390.33
346.31
▼ -11.3%
8
12
SMA10 target
381.88
▼ -9.3%
No
ZBRA
A
2026-11-02
368.25
322.02
▼ -12.6%
5
15
SMA10 target
355.59
▼ -9.4%
No
MPC
A
2026-10-28
441.85
372.66
▼ -15.7%
8
12
SMA10 target
422.50
▼ -11.8%
No
TMO
B
2026-09-17
654.57
695.08
▲ +6.2%
37
—
Don10 model end line
662.50
▲ +4.9%
No
HUM
B
2026-10-12
435.99
432.97
▼ -0.7%
20
—
Don10 model end line
399.35
▲ +8.4%
No

Latest-quote context (context only; model markers unchanged)

InstrumentTypeReference closeAfter-hours (as of 17:40 ET)Quote time ETvs referenceStart or triggervs start or triggerNearest model levelvs levelCrossing hint
FTNT
Model position
118.84
118.84
17:12
– +0.0%
133.80
▼ -11.2%
144.27
▼ -17.6%
Not crossed
VLO
Model position
346.31
346.73
17:29
▲ +0.1%
390.33
▼ -11.2%
381.88
▼ -9.2%
Not crossed
ZBRA
Model position
322.02
—
—
—
—
—
—
—
No extended-hours trade
MPC
Model position
372.66
374.00
17:17
▲ +0.4%
441.85
▼ -15.4%
422.50
▼ -11.5%
Not crossed
TMO
Model position
695.08
694.76
16:51
▼ -0.0%
654.57
▲ +6.1%
662.50
▲ +4.9%
Not crossed
HUM
Model position
432.97
433.74
16:58
▲ +0.2%
435.99
▼ -0.5%
399.35
▲ +8.6%
Not crossed
PSX
Queued
245.68
—
—
—
—
—
—
—
No extended-hours trade
NTAP
Queued
169.19
172.75
17:11
▲ +2.1%
—
—
—
—
Not crossed

Model markers

InstrumentLegReference priceRS percentileResidual zModel queueLeg A target lineLeg B model end line
PSX
A
245.68
96%
-3.20
Queued (slots full)
268.69
—
NTAP
A
169.19
95%
-1.68
Queued (slots full)
199.32
—

Next-day model end records

Source lists 0 rows 0.

Recent model records

InstrumentLegModel startModel endModel start priceModel end priceHistorical price changeModel elapsed daysReason
INTC
A
2026-10-09
2026-10-28
107.08
93.74
▼ -12.5%
13
Close 93.74 ≥ SMA10 91.67 (target reached)
STX
A
2026-10-09
2026-10-28
774.83
667.85
▼ -13.8%
13
Close 667.85 ≥ SMA10 666.09 (target met)
DELL
A
2026-10-16
2026-10-28
473.39
501.96
▲ +6.0%
8
Close 501.96 ≥ SMA10 471.17 (target met)
DXCM
A
2026-10-27
2026-11-02
78.57
82.29
▲ +4.7%
4
Close 82.29 ≥ SMA10 80.62 (target reached)
PSX
A
2026-10-28
2026-11-02
268.53
282.83
▲ +5.3%
3
Close 282.83 ≥ SMA10 282.70 (target reached)

BIO

Observation date: 2026-11-06

ItemReading
NAV
24.70
Year to date
▲ +30.5%
Slots
3
XBI gate
Open
XBI
152.19
XBI SMA200
142.24
Latest quote
After-hours
Quote as of ET
17:40
Symbols quoted
2 / 3

Simulated positions

InstrumentModel start dateModel start priceLatest close (as of 2026-11-06)Historical price changeModel upper boundSMA50Consecutive days below SMA50Model half closed
CRL
2026-08-05
260.98
337.36
▲ +29.3%
365.37
305.59
0
Yes
EXEL
2026-10-30
69.46
69.57
▲ +0.2%
97.24
60.92
0
No
MRNA
2026-10-09
225.22
254.19
▲ +12.9%
315.31
191.85
0
No

Latest-quote context (context only; model markers unchanged)

InstrumentTypeReference closeAfter-hours (as of 17:40 ET)Quote time ETvs referenceStart or triggervs start or triggerNearest model levelvs levelCrossing hint
CRL
Model position
337.36
337.52
16:50
▲ +0.0%
260.98
▲ +29.3%
365.37
▼ -7.6%
Not crossed
EXEL
Model position
69.57
—
—
—
—
—
—
—
No extended-hours trade
MRNA
Model position
254.19
256.27
17:35
▲ +0.8%
225.22
▲ +13.8%
315.31
▼ -18.7%
Not crossed

Model markers

Source lists 0 rows 0.

Recent model records

InstrumentModel startModel endModel start priceModel end priceHistorical price changeReason
HUM
2026-05-18
2026-08-05
305.59
363.82
▲ +18.9%
Model trend close
CVS
2026-07-16
2026-08-06
105.20
95.54
▼ -9.3%
Model trend close
LQDA
2026-06-09
2026-08-14
64.07
74.44
▲ +16.1%
Model trend close after half
RGEN
2026-08-17
2026-10-08
169.21
163.84
▼ -3.3%
Model trend close
IOVA
2026-08-06
2026-10-30
6.22
8.48
▲ +36.3%
Model trend close after half

Catalyst calendar

InstrumentDateTypeNote
BIIB
2026-12-01
P3 completion window
A Study to Learn More About the Effects and Safety of Felzar
EXEL
2026-12-15
P3 completion window
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Adv
IONS
2026-12-15
P3 completion window
A Study to Assess the Long-Term Safety and Efficacy of Donid
AXSM
2026-12-15
P3 completion window
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and No
AXSM
2026-12-15
P3 completion window
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Ea
MDGL
2026-12-15
P3 completion window
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clin
KRYS
2026-12-15
P3 completion window
A Study Comparing KB803 and Matched Placebo in Patients With
INCY
2026-12-26
P3 completion window
A Study to Evaluate the Long-Term Safety and Efficacy of Pov

Corporate events

SymbolEventLast trading dateCompletionCash considerationExchange ratioSuccessor companyAcquirer
ACLX
cash
2026-04-27
2026-04-28
115.00
—
—
Gilead Sciences
AKRO
cash
2025-12-08
2025-12-09
54.00
—
—
Novo Nordisk
APLS
cash
2026-05-13
2026-05-14
41.00
—
—
Biogen
CPRX
cash
2026-07-14
2026-07-15
31.50
—
—
Angelini Pharma
DVAX
cash
2026-02-09
2026-02-10
15.50
—
—
Sanofi
EXAS
cash
2026-03-20
2026-03-23
105.00
—
—
Abbott Laboratories
FOLD
cash
2026-04-24
2026-04-27
14.50
—
—
BioMarin Pharmaceutical
HOLX
cash
2026-04-06
2026-04-07
76.00
—
—
Blackstone/TPG (Hopper Parent)
NUVL
cash
2026-07-14
2026-07-15
124.00
—
—
GSK
SAGE
cash
2025-07-30
2025-07-31
8.50
—
—
Supernus Pharmaceuticals
SUPN
stock
2026-10-30
2026-11-02
0.00
1.5401
INDV
—

Research report for general information. Includes model outputs. Not personalized, not investment advice, and not a recommendation to buy or sell. We do not manage accounts. Data as of 2026-11-06. No performance is guaranteed.

Historical simulation, not live trading. Not a recommendation to buy or sell.

Need research on your holdings? Request it in My Axiocairn.